FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085118852> ?p ?o ?g. }

• W2085118852 endingPage "304" @default.
• W2085118852 startingPage "295" @default.
• W2085118852 abstract "The aminoacyl-β-ketophosphonate-adenosines (aa-KPA) are stable analogs of the aminoacyl adenylates, which are high-energy intermediates in the formation of aminoacyl-tRNA catalyzed by aminoacyl-tRNA synthetases (aaRS). We have synthesized glutamyl-β-ketophosphonate-adenosine (Glu-KPA) and glutaminyl-β-ketophosphonate-adenosine (Gln-KPA), and have tested them as inhibitors of their cognate aaRS, and of a non-cognate aaRS. Glu-KPA is a competitive inhibitor of Escherichia coli glutamyl-tRNA synthetase (GluRS) with a Ki of 18 μM with respect to its substrate glutamate, and binds at one site on this monomeric enzyme; the non-cognate Gln-KPA also binds this GluRS at one site, but is a much weaker (Ki = 2.9 mM) competitive inhibitor. By contrast, Gln-KPA inhibits E. coli glutaminyl-tRNA synthetase (GlnRS) by binding competitively but weakly at two distinct sites on this enzyme (average Ki of 0.65 mM); the non-cognate Glu-KPA shows one-site weak (Ki = 2.8 mM) competitive inhibition of GlnRS. These kinetic results indicate that the glutamine and the AMP modules of Gln-KPA, connected by the β-ketophosphonate linker, cannot bind GlnRS simultaneously, and that one Gln-KPA molecule binds the AMP-binding site of GlnRS through its AMP module, whereas another Gln-KPA molecule binds the glutamine-binding site through its glutamine module. This model suggests that similar structural constraints could affect the binding of Glu-KPA to the active site of mammalian cytoplasmic GluRSs, which are evolutionarily much closer to bacterial GlnRS than to bacterial GluRS. This possibility was confirmed by the fact that Glu-KPA inhibits bovine liver GluRS 145-fold less efficiently than E. coli GluRS by competitive weak binding at two distinct sites (average Ki = 2.6 mM). Moreover, these kinetic differences reveal that the active sites of bacterial GluRSs and mammalian cytoplasmic GluRSs have substantial structural differences that could be further exploited for the design of better inhibitors specific for bacterial GluRSs, promising targets for antimicrobial therapy." @default.
• W2085118852 created "2016-06-24" @default.
• W2085118852 creator A5001086636 @default.
• W2085118852 creator A5006682222 @default.
• W2085118852 creator A5020797052 @default.
• W2085118852 creator A5060154506 @default.
• W2085118852 creator A5071303491 @default.
• W2085118852 creator A5082328497 @default.
• W2085118852 creator A5088041911 @default.
• W2085118852 date "2007-01-01" @default.
• W2085118852 modified "2023-10-17" @default.
• W2085118852 title "Synthesis of β-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases" @default.
• W2085118852 cites W153087452 @default.
• W2085118852 cites W1577843618 @default.
• W2085118852 cites W1654980460 @default.
• W2085118852 cites W1966317480 @default.
• W2085118852 cites W1978505998 @default.
• W2085118852 cites W1979172475 @default.
• W2085118852 cites W1981160385 @default.
• W2085118852 cites W1981529363 @default.
• W2085118852 cites W1994276053 @default.
• W2085118852 cites W2017102688 @default.
• W2085118852 cites W2018756788 @default.
• W2085118852 cites W2033666084 @default.
• W2085118852 cites W2035015603 @default.
• W2085118852 cites W2042940085 @default.
• W2085118852 cites W2053093232 @default.
• W2085118852 cites W2055994414 @default.
• W2085118852 cites W2066479660 @default.
• W2085118852 cites W2085791091 @default.
• W2085118852 cites W2091198719 @default.
• W2085118852 cites W2095554932 @default.
• W2085118852 cites W2115227691 @default.
• W2085118852 cites W2140885472 @default.
• W2085118852 cites W2342497210 @default.
• W2085118852 cites W2398031338 @default.
• W2085118852 cites W2951245851 @default.
• W2085118852 cites W635049068 @default.
• W2085118852 doi "https://doi.org/10.1016/j.bmc.2006.09.056" @default.
• W2085118852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17049867" @default.
• W2085118852 hasPublicationYear "2007" @default.
• W2085118852 type Work @default.
• W2085118852 sameAs 2085118852 @default.
• W2085118852 citedByCount "33" @default.
• W2085118852 countsByYear W20851188522012 @default.
• W2085118852 countsByYear W20851188522014 @default.
• W2085118852 countsByYear W20851188522015 @default.
• W2085118852 countsByYear W20851188522016 @default.
• W2085118852 countsByYear W20851188522017 @default.
• W2085118852 countsByYear W20851188522021 @default.
• W2085118852 countsByYear W20851188522023 @default.
• W2085118852 crossrefType "journal-article" @default.
• W2085118852 hasAuthorship W2085118852A5001086636 @default.
• W2085118852 hasAuthorship W2085118852A5006682222 @default.
• W2085118852 hasAuthorship W2085118852A5020797052 @default.
• W2085118852 hasAuthorship W2085118852A5060154506 @default.
• W2085118852 hasAuthorship W2085118852A5071303491 @default.
• W2085118852 hasAuthorship W2085118852A5082328497 @default.
• W2085118852 hasAuthorship W2085118852A5088041911 @default.
• W2085118852 hasConcept C104317684 @default.
• W2085118852 hasConcept C107824862 @default.
• W2085118852 hasConcept C153957851 @default.
• W2085118852 hasConcept C160403918 @default.
• W2085118852 hasConcept C180526460 @default.
• W2085118852 hasConcept C181199279 @default.
• W2085118852 hasConcept C185592680 @default.
• W2085118852 hasConcept C2779315393 @default.
• W2085118852 hasConcept C2779349466 @default.
• W2085118852 hasConcept C2910418148 @default.
• W2085118852 hasConcept C41183919 @default.
• W2085118852 hasConcept C515207424 @default.
• W2085118852 hasConcept C547475151 @default.
• W2085118852 hasConcept C553450214 @default.
• W2085118852 hasConcept C55493867 @default.
• W2085118852 hasConcept C67705224 @default.
• W2085118852 hasConcept C71240020 @default.
• W2085118852 hasConceptScore W2085118852C104317684 @default.
• W2085118852 hasConceptScore W2085118852C107824862 @default.
• W2085118852 hasConceptScore W2085118852C153957851 @default.
• W2085118852 hasConceptScore W2085118852C160403918 @default.
• W2085118852 hasConceptScore W2085118852C180526460 @default.
• W2085118852 hasConceptScore W2085118852C181199279 @default.
• W2085118852 hasConceptScore W2085118852C185592680 @default.
• W2085118852 hasConceptScore W2085118852C2779315393 @default.
• W2085118852 hasConceptScore W2085118852C2779349466 @default.
• W2085118852 hasConceptScore W2085118852C2910418148 @default.
• W2085118852 hasConceptScore W2085118852C41183919 @default.
• W2085118852 hasConceptScore W2085118852C515207424 @default.
• W2085118852 hasConceptScore W2085118852C547475151 @default.
• W2085118852 hasConceptScore W2085118852C553450214 @default.
• W2085118852 hasConceptScore W2085118852C55493867 @default.
• W2085118852 hasConceptScore W2085118852C67705224 @default.
• W2085118852 hasConceptScore W2085118852C71240020 @default.
• W2085118852 hasIssue "1" @default.
• W2085118852 hasLocation W20851188521 @default.
• W2085118852 hasLocation W20851188522 @default.
• W2085118852 hasOpenAccess W2085118852 @default.
• W2085118852 hasPrimaryLocation W20851188521 @default.

• next